Breeze Digital Inflation Device
by Namic
510(k) K953676
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK953676 | Date29 Mar 1996 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MAV
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1650
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Breeze Digital Inflation Device is a Syringe, Balloon Inflation (product code MAV), designed for precise inflation and deflation of angioplasty balloons in cardiovascular procedures. It features a non-software-driven solid-state digital gauge for accurate pressure measurement, ensuring controlled inflation during interventional radiology and cardiology applications.
This device is supplied as a reusable medical instrument, intended for use in sterile environments such as catheterization labs and operating rooms. It adheres to FDA Class II regulatory standards under Regulation 870.1650, with an FDA 510(k) clearance (K953676) granted in 1996. No MRI safety classification or single-use designation is specified in the available data.
Other devices from Namic
Questions
AI-generated answers, 19 Sep 2026
Is the Breeze Digital Inflation Device intended for single-use or can it be reused in multiple procedures?
The Breeze Digital Inflation Device is explicitly described as a reusable medical instrument. Since it is designed for use in sterile environments like catheterization labs and operating rooms, it must be properly cleaned, disinfected, and sterilized between uses to maintain safety and performance standards.
What types of cardiovascular procedures is the Breeze Digital Inflation Device primarily used for?
The device is specifically designed for precise inflation and deflation of angioplasty balloons during interventional radiology and cardiology procedures. This includes applications where controlled pressure is critical, such as percutaneous coronary interventions (PCI) or peripheral angioplasty.
How is the Breeze Digital Inflation Device regulated, and what does its FDA clearance status mean for buyers?
The Breeze Digital Inflation Device holds an FDA 510(k) clearance (K953676) under Class II regulatory standards, granted in 1996. This means it has been determined to be substantially equivalent to a legally marketed device and meets FDA requirements for safety and effectiveness. Buyers can rely on this clearance as evidence of regulatory compliance for use in sterile environments like catheterization labs.
Does the Breeze Digital Inflation Device include any software-dependent features, or is it purely hardware-based?
The device features a non-software-driven solid-state digital gauge, meaning its pressure measurement functionality relies entirely on hardware components rather than software. This design ensures reliability and eliminates potential software-related malfunctions during critical procedures.
What storage or handling considerations should be taken into account for the Breeze Digital Inflation Device?
While the device is reusable, no specific storage instructions (e.g., temperature, humidity, or shelf life) are provided in the available data. However, since it is intended for sterile environments, it should be stored in a clean, dry location when not in use and undergo proper cleaning, disinfection, and sterilization protocols between procedures to maintain its integrity and performance.